We are a coalition of doctors, researchers, patients, and entrepreneurs pioneering a new approach to curing diseases through innovative outcome-based financing. We collaborate with impact investors and payers to discover life-altering therapies and bring them to patients.
We at Mission: Cure stand in solidarity with the Black community, the Black Lives Matter movement, and efforts to end systemic racism. We commit to look into ourselves as individuals and as an organization and to do more to advance anti-racism in everything we do.
The first disease we are attacking is pancreatitis. The world’s top pancreatic experts believe a well-funded, coordinated research and development program could lead to effective treatments within 10 years. Mission: Cure is working to make that happen. Consulting with pancreatic experts from the nation’s top research and healthcare institutions, we developed a 10-year plan and are working to implement it.
The time is right to create a new model for curing disease. Exciting developments in genetics and data are making precision medicine a reality. Healthcare payers are moving toward value-based funding, especially for chronic diseases. And a new generation of impact investors—seeking to generate social and not just financial returns—have made curing disease a priority.
News from Mission: Cure
Dosing Pancreatic Enzymes for Adults
Watch our Webinar on Pancreatitis Diagnosis: Living With Pancreatitis
Mission: Cure – Blog